Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection

Mise à jour : Il y a 4 ans
Référence : NCT00183261

Femme et Homme

Extrait

The purpose of this study is to determine whether the HIV vaccine MRKAd5 HIV-1 gag/pol/nef followed by treatment interruption can increase immune system function in adults with acute or recent HIV infection who have started taking anti-HIV drugs.


Critère d'inclusion

  • HIV Infections

Liens